NCT00978198View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

ASP1517

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00978198 - Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers | Biotech Hunter | Biotech Hunter